The research, funded by the British Heart Foundation and published in the journal Circulation, opens the prospect of treating the condition at the earliest stages.
CEB-01 by Cebiotex for Nerve Sheath Tumor: Likelihood of Approval
CEB-01 is under clinical development by Cebiotex and currently in Phase I for Nerve Sheath Tumor.